resveratrol has been researched along with Cancer of Pancreas in 52 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (1.92) | 18.2507 |
| 2000's | 8 (15.38) | 29.6817 |
| 2010's | 33 (63.46) | 24.3611 |
| 2020's | 10 (19.23) | 2.80 |
| Authors | Studies |
|---|---|
| Andrus, MB; Brewer, KI; Osmond, G; Tyler, DS; Wong, Y | 1 |
| Gu, J; Huang, X; Jiang, H; Ma, Q; Sha, H; Wang, G; Wang, P; Wang, Z; Xiao, Y | 1 |
| Islam, MK; Lian, HK; Lim, JCW; Sagineedu, SR; Selvarajoo, N; Stanslas, J | 1 |
| Grau, L; Pujol, MD; Soucek, R | 1 |
| Amoroso, R; Brocco, D; Cacciatore, I; Cama, A; Cataldi, A; Catitti, G; De Filippis, B; De Lellis, L; di Giacomo, V; di Rienzo, A; Florio, R; Lanuti, P; Veschi, S | 1 |
| Bloebaum, P; Jurisson, SS; Katti, KK; Katti, KV; Khoobchandani, M; Panjtan Amiri, K; Raphael Karikachery, A; Thipe, VC | 1 |
| Becer, E; Hoca, M; Kabadayı, H; Vatansever, HS; Yücecan, S | 1 |
| Baer-Dubowska, W; Cykowiak, M; Kleszcz, R; Krajka-Kuźniak, V; Szaefer, H | 1 |
| Aasbrenn, M; Abd El-Aty, AM; Abdu, A; Abraha, HB; Achour, A; Acquaroni, M; Addeo, P; Agback, P; Agback, T; Al-Alwan, M; Al-Mazrou, A; Al-Mohanna, F; Aliste, M; Almquist, J; Andel, J; Ando, M; Angelov, A; Annuar, MSM; Antwi, K; Arroliga, AC; Arruda, SLM; Asch, SM; Averous, G; Ayaz, S; Ayer, GB; Bachellier, P; Ball, S; Banijamali, AR; Barden, TC; Bartoncini, S; Bedanie, G; Bellò, M; Benić, F; Berhe, GG; Bertiger, G; Beumer, JH; Bhandari, B; Bond, DS; Boules, M; Braüner Christensen, J; Brown-Johnson, C; Burgstaller, S; Cao, L; Capasso, C; Carlevato, R; Carvalho, AE; Ceci, F; Chagas, ATA; Chavan, SG; Chen, AP; Chen, HC; Chen, J; Chen, Q; Chen, Y; Chen, YF; Christ, ER; Chu, CW; Covey, JM; Coyne, GO'; Cristea, MC; Currie, MG; Dahdal, DN; Dai, L; Dang, Z; de Abreu, NL; de Carvalho, KMB; de la Plaza Llamas, R; Deandreis, D; Del Prete, S; Dennis, JA; Deur, J; Díaz Candelas, DA; Divyapriya, G; Djanani, A; Dodig, D; Doki, Y; Doroshow, JH; Dos Santos, RC; Durairaj, N; Dutra, ES; Eguchi, H; Eisterer, W; Ekmann, A; Elakkad, A; Evans, WE; Fan, W; Fang, Z; Faria, HP; Farris, SG; Fenoll, J; Fernandez-Botran, R; Flores, P; Fujita, J; Gan, L; Gandara, DR; Gao, X; Garcia, AA; Garrido, I; Gebru, HA; Gerger, A; Germano, P; Ghamande, S; Ghebeh, H; Giver Jensen, T; Go, A; Goichot, B; Goldwater, M; Gontero, P; Greil, R; Gruenberger, B; Guarneri, A; Guo, Y; Gupta, S; Haxholdt Lunn, T; Hayek, AJ; He, ML; Hellín, P; Hepprich, M; Hernández de Rodas, E; Hill, A; Hndeya, AG; Holdsworth, LM; Hookey, L; Howie, W; Hu, G; Huang, JD; Huang, SY; Hubmann, E; Hwang, SY; Imamura, H; Imperiale, A; Jiang, JQ; Jimenez, JL; Jin, F; Jin, H; Johnson, KL; Joseph, A; Juwara, L; Kalapothakis, E; Karami, H; Karayağiz Muslu, G; Kawabata, R; Kerwin, J; Khan, I; Khin, S; Kidanemariam, HG; Kinders, RJ; Klepov, VV; Koehler, S; Korger, M; Kovačić, S; Koyappayil, A; Kroll, MH; Kuban, J; Kummar, S; Kung, HF; Kurokawa, Y; Laengle, F; Lan, J; Leal, HG; Lee, MH; Lemos, KGE; Li, B; Li, G; Li, H; Li, X; Li, Y; Li, Z; Liebl, W; Lillaz, B; Lin, F; Lin, L; Lin, MCM; Lin, Y; Lin, YP; Lipton, RB; Liu, J; Liu, W; Liu, Z; Lu, J; Lu, LY; Lu, YJ; Ludwig, S; Luo, Y; Ma, L; Ma, W; Machado-Coelho, GLL; Mahmoodi, B; Mahoney, M; Mahvash, A; Mansour, FA; Mao, X; Marinho, CC; Masferrer, JL; Matana Kaštelan, Z; Melendez-Araújo, MS; Méndez-Chacón, E; Miletić, D; Miller, B; Miller, E; Miller, SB; Mo, L; Moazzen, M; Mohammadniaei, M; Montaz-Rosset, MS; Mousavi Khaneghah, A; Mühlethaler, K; Mukhopadhyay, S; Mulugeta, A; Nambi, IM; Navarro, S; Nazmara, S; Neumann, HJ; Newman, EM; Nguyen, HTT; Nicolato, AJPG; Nicolotti, DG; Nieva, JJ; Nilvebrant, J; Nocentini, A; Nugent, K; Nunez-Rodriguez, DL; Nygren, PÅ; Oberli, A; Oderda, M; Odisio, B; Oehler, L; Otludil, B; Overman, M; Özdemir, M; Pace, KA; Palm, H; Parchment, RE; Parise, R; Passera, R; Pavlovic, J; Pecherstorfer, M; Peng, Z; Pérez Coll, C; Petzer, A; Philipp-Abbrederis, K; Pichler, P; Piekarz, RL; Pilati, E; Pimentel, JDSM; Posch, F; Prager, G; Pressel, E; Profy, AT; Qi, P; Qi, Y; Qiu, C; Rajasekhar, B; Ramia, JM; Raynor, HA; Reis, VW; Reubi, JC; Ricardi, U; Riedl, JM; Romano, F; Rong, X; Rubinstein, L; Rumboldt, Z; Sabir, S; Safaeinili, N; Sala, BM; Sandoval Castillo, L; Sau, M; Sbhatu, DB; Schulte, T; Scott, V; Shan, H; Shao, Y; Shariatifar, N; Shaw, JG; She, Y; Shen, B; Shernyukov, A; Sheth, RA; Shi, B; Shi, R; Shum, KT; Silva, JC; Singh, A; Sinha, N; Sirajudeen, AAO; Slaven, J; Sliwa, T; Somme, F; Song, S; Steinberg, SM; Subramaniam, R; Suetta, C; Sui, Y; Sun, B; Sun, C; Sun, H; Sun, Y; Supuran, CT; Surger, M; Svartz, G; Takahashi, T; Takeno, A; Tam, AL; Tang, Z; Tanner, JA; Tannich, E; Taye, MG; Tekle, HT; Thomas, GJ; Tian, Y; Tobin, JV; Todd Milne, G; Tong, X; Une, C; Vela, N; Venkateshwaran, U; Villagrán de Tercero, CI; Wakefield, JD; Wampfler, R; Wan, M; Wang, C; Wang, J; Wang, L; Wang, S; Waser, B; Watt, RM; Wei, B; Wei, L; Weldemichael, MY; Wellmann, IA; Wen, A; Wild, D; Wilthoner, K; Winder, T; Wing, RR; Winget, M; Wöll, E; Wong, KL; Wong, KT; Wu, D; Wu, Q; Wu, Y; Xiang, T; Xiang, Z; Xu, F; Xu, L; Yamasaki, M; Yamashita, K; Yan, H; Yan, Y; Yang, C; Yang, H; Yang, J; Yang, N; Yang, Y; Yau, P; Yu, M; Yuan, Q; Zhan, S; Zhang, B; Zhang, H; Zhang, J; Zhang, N; Zhang, Y; Zhao, X; Zheng, BJ; Zheng, H; Zheng, W; Zhou, H; Zhou, X; Zhu, S; Zimmer, DP; Zionts, D; Zitella, A; Zlott, J; Zolfaghari, K; Zuo, D; Zur Loye, HC; Žuža, I | 1 |
| Abrego, J; Attri, KS; Buettner, K; Chaika, NV; Dasgupta, A; Engle, DD; Grandgenett, PM; Graves, G; Hollingsworth, MA; King, RJ; Klute, KA; Mehla, K; Mulder, SE; Mullen, NJ; Murthy, D; Oberley-Deegan, R; Pacheco, CG; Punsoni, M; Rai, I; Reames, BN; Sadoshima, J; Shukla, SK; Singh, PK; Teoh-Fitzgerald, M; Thakur, R; Tuveson, DA; Vernucci, E; Wang, D; Yu, F; Zimmerman, MC | 1 |
| Alam, A; Aliya, S; Behera, SK; Dariya, B; Nagaraju, GP; Srivani, G | 1 |
| Li, J; Liu, J; Liu, Y; Qi, Z; Shen, Y; Tian, W; Yang, L; Yang, Y; Zhang, Q; Zhu, M | 1 |
| Baer-Dubowska, W; Cykowiak, M; Krajka-Kuźniak, V | 1 |
| Cao, J; Chen, K; Cheng, L; Jiang, Z; Li, J; Ma, J; Ma, Q; Qian, W; Sha, H; Sun, L; Yan, B; Zhou, C | 1 |
| Barros, AS; Correia, IJ; Costa, EC; de Melo-Diogo, D; Nunes, AS | 1 |
| Cao, J; Cheng, L; Duan, W; Jiang, Z; Li, J; Li, X; Ma, J; Ma, Q; Qian, W; Sun, L; Wang, F; Wu, E; Wu, Z; Yan, B; Zhou, C | 1 |
| Fu, J; Shankar, S; Shrivastava, A; Shrivastava, SK; Srivastava, RK | 1 |
| Amintas, S; Bedel, A; Belleannée, G; Buscail, E; Chiche, L; Coulibaly, S; Dabernat, S; Dupin, C; Lamrissi, I; Moranvillier, I; Moreau-Gaudry, F; Noel, C; Rousseau, B; Vendrely, V | 1 |
| Duan, W; Han, L; Li, B; Li, W; Liu, J; Ma, J; Ma, Q; Wang, F; Wu, E; Xu, Q; Yu, S | 1 |
| Li, J; Liu, F; Liu, J; Liu, Q; Qi, Z; Shen, Y; Tian, W; Yang, L; Yang, Y; Zhang, Q; Zhang, Y; Zhu, M | 1 |
| DiPette, DJ; Hu, J; Kumar, A; LaVoie, HA; Singh, US; Walsh, KB | 1 |
| Dang, X; Li, W; Ma, Q; Ma, Z; Qin, Y | 1 |
| Chen, X; Duan, W; Jiang, Z; Lei, J; Li, J; Li, X; Ma, J; Ma, Q; Ma, Z; Nan, L; Wang, Z; Wu, Z; Xu, Q; Zhang, L; Zong, L | 1 |
| Hayashi, K; Hori, Y; Joh, T; Kato, A; Kato, H; Kondo, H; Kuno, T; Miyabe, K; Mori, T; Naiki-Ito, A; Naitoh, I; Nakazawa, T; Nishi, Y; Ohara, H; Shimizu, S; Suzuki, S; Takahashi, S; Tsutsumi, M; Umemura, S; Yoshida, M | 1 |
| Cao, L; Chen, X; Lei, J; Li, W; Ma, Q | 1 |
| Cao, L; Chen, X; Li, W; Ma, Q; Xiao, X | 1 |
| Borska, S; Danielewicz, M; Drag-Zalesinska, M; Dziegiel, P; Gomulkiewicz, A; Nowinska, K; Olbromski, M; Pedziwiatr, M; Pula, B | 1 |
| Duan, J; E, J; Gu, J; Lu, SE; Malhotra, J; Tan, XL; Xu, F; Yue, W | 1 |
| Chen, K; Chen, X; Duan, W; Gao, L; Jiang, Z; Lei, M; Ma, J; Ma, Q; Sun, L; Wang, Z; Zhou, C | 1 |
| Kang, L; Li, J; Li, Y; Liu, J; Liu, Y; Qi, Z; Shen, Y; Wang, X; Yang, L; Yang, Y; Zhang, Q; Zhu, M; Zu, L | 1 |
| Bedel, A; Brillac, A; Buscail, E; Dabernat, S; de Verneuil, H; Moranvillier, I; Moreau-Gaudry, F; Peuchant, E; Rousseau, B; Vendrely, V | 1 |
| Bae, I; Baruchello, R; Dakshanamurthy, S; Daniele, S; Grisolia, G; Hong, YB; Kang, HJ; Kim, HJ; Rondanin, R; Rosen, EM | 1 |
| Bortolotti, C; Fürst, J; Geibel, JP; Hartl, A; Hufnagl, C; Jakab, M; Kunit, T; Langelueddecke, C; Moder, A; Ritter, M; Schmidt, S | 1 |
| Aggarwal, BB; Anand, P; Diagaradjane, P; Gelovani, J; Guha, S; Harikumar, KB; Krishnan, S; Kunnumakkara, AB; Pandey, MK; Sethi, G | 1 |
| Anant, S; Houchen, CW; Ramalingam, S; Subramaniam, D | 1 |
| Feick, P; Gerloff, A; Singer, MV | 1 |
| Bode, AM; Cho, YY; Dong, Z; Jeong, CH; Nadas, J; Oi, N; Pugliese, A | 1 |
| Cui, J; Gou, S; Sun, R; Wang, C; Yu, Y; Zhao, G | 1 |
| Meeker, D; Nall, D; Passarini, J; Shankar, S; Sharma, J; Srivastava, RK; Tang, SN | 1 |
| Albanyan, A; Azmi, AS; Banerjee, S; Bao, B; Beck, FW; Hadi, SM; Hanif, S; Mohammad, RM; Sarkar, FH; Shamim, U; Wang, Z | 1 |
| Cheng, HY; He, DW; Pan, Z; Yang, DT; Yu, ZQ; Zhou, JH | 1 |
| Chen, Q; Fu, J; Roy, SK; Shankar, S; Srivastava, RK | 1 |
| Garcia-Sanchez, L; Gonzalez, A; Miro-Moran, A; Salido, GM; Santofimia-Castaño, P; Tapia, JA | 1 |
| Guo, C; Ke, A; Mo, W; Wang, F; Wang, X; Xu, L; Xu, X | 1 |
| Boreddy, SR; Srivastava, SK | 1 |
| Kong, H; Lei, P; Li, P; Liang, H; Liu, P; Tu, Z; Wang, S; Xia, Q | 1 |
| Adrian, TE; Ding, XZ | 1 |
| Debatin, KM; Fulda, S | 1 |
| Hirose, M; Ishii, Y; Kanki, K; Kitamura, Y; Kuroiwa, Y; Nishikawa, A; Umemura, T | 1 |
| Adrian, TE; Bell, RH; Bentrem, DJ; Ding, XZ; Fought, AJ; Golkar, L; Kelly, DL; Salabat, MR; Scholtens, D; Talamonti, MS; Ujiki, MB | 1 |
| Keng, P; Kim, J; Liu, C; Okunieff, P; Sun, W; Wang, W; Yang, S; Zhang, H; Zhang, L | 1 |
| Baumgartner, G; Hamilton, G; Hejna, M; Hoffmann, O; Mallinger, R; Raderer, M; Ulsperger, E | 1 |
5 review(s) available for resveratrol and Cancer of Pancreas
| Article | Year |
|---|---|
Pharmacological Modulation of Apoptosis and Autophagy in Pancreatic Cancer Treatment.
Topics: Antineoplastic Agents; Apoptosis; Autophagy; Cell Line, Tumor; Cell Proliferation; Chloroquine; ErbB Receptors; Fluorouracil; Humans; Metformin; Pancreatic Neoplasms; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Resveratrol; Sirolimus; TOR Serine-Threonine Kinases | 2022 |
Resveratrol in the treatment of pancreatic cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle Checkpoints; Cell Proliferation; Humans; Pancreatic Neoplasms; Resveratrol; Stilbenes | 2015 |
Cancer stem cells: a novel paradigm for cancer prevention and treatment.
Topics: AC133 Antigen; Antigens, CD; Breast Neoplasms; Colonic Neoplasms; Curcumin; Female; Glycoproteins; Hedgehog Proteins; Humans; Neoplastic Stem Cells; Pancreatic Neoplasms; Peptides; Protein Serine-Threonine Kinases; Receptors, Notch; Resveratrol; Signal Transduction; Stilbenes | 2010 |
Beer and its non-alcoholic compounds: role in pancreatic exocrine secretion, alcoholic pancreatitis and pancreatic carcinoma.
Topics: Beer; Catechin; Ellagic Acid; Humans; Oxidative Stress; Pancreas; Pancreatic Neoplasms; Pancreatitis, Alcoholic; Quercetin; Resveratrol; Stilbenes | 2010 |
Pancreatic cancer chemoprevention by phytochemicals.
Topics: Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Capsaicin; Curcumin; Humans; Isothiocyanates; Pancreatic Neoplasms; Phytochemicals; Resveratrol; Stilbenes; Tea | 2013 |
1 trial(s) available for resveratrol and Cancer of Pancreas
46 other study(ies) available for resveratrol and Cancer of Pancreas
| Article | Year |
|---|---|
Synthesis of 4'-ester analogs of resveratrol and their evaluation in malignant melanoma and pancreatic cell lines.
Topics: Antineoplastic Agents; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Esters; HL-60 Cells; Humans; Melanoma; Pancreatic Neoplasms; Resveratrol; Stilbenes; Structure-Activity Relationship | 2010 |
Resveratrol inhibits the expression of RYR2 and is a potential treatment for pancreatic cancer.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Movement; Cell Proliferation; Gene Knockdown Techniques; Humans; Neoplasm Invasiveness; Pancreatic Neoplasms; PTEN Phosphohydrolase; Resveratrol; Ryanodine Receptor Calcium Release Channel | 2022 |
Resveratrol derivatives: Synthesis and their biological activities.
Topics: Adenocarcinoma; Antineoplastic Agents; Antioxidants; Humans; Pancreatic Neoplasms; Resveratrol; Stilbenes | 2023 |
Resveratrol Derivative Exhibits Marked Antiproliferative Actions, Affecting Stemness in Pancreatic Cancer Cells.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Humans; Neoplastic Stem Cells; Pancreatic Neoplasms; Polyphenols; Resveratrol | 2023 |
Development of resveratrol-conjugated gold nanoparticles: interrelationship of increased resveratrol corona on anti-tumor efficacy against breast, pancreatic and prostate cancers.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Shape; Cell Survival; Endocytosis; Female; Gold; Humans; Inhibitory Concentration 50; Male; Metal Nanoparticles; Pancreatic Neoplasms; Particle Size; Polyphenols; Prostatic Neoplasms; Resveratrol; Spectrophotometry, Ultraviolet; Treatment Outcome | 2019 |
The Effect of Resveratrol and Quercetin on Epithelial-Mesenchymal Transition in Pancreatic Cancer Stem Cell.
Topics: Antigens, CD; Antineoplastic Agents; Cadherins; Cell Line, Tumor; Cell Proliferation; Cell Survival; Epithelial-Mesenchymal Transition; Humans; Neoplastic Stem Cells; Pancreatic Neoplasms; Quercetin; Resveratrol; Tumor Necrosis Factor-alpha; Vimentin | 2020 |
Combination of xanthohumol and phenethyl isothiocyanate inhibits NF-κB and activates Nrf2 in pancreatic cancer cells.
Topics: Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Synergism; Flavonoids; Humans; Indoles; Isothiocyanates; NF-E2-Related Factor 2; NF-kappa B; Pancreatic Neoplasms; Propiophenones; Resveratrol | 2020 |
SIRT1-NOX4 signaling axis regulates cancer cachexia.
Topics: Adipose Tissue; Animals; Cachexia; Cell Line; Cell Line, Tumor; Disease Models, Animal; Disease Progression; Forkhead Transcription Factors; HEK293 Cells; Humans; Metabolome; Mice; Muscle Fibers, Skeletal; Muscle, Skeletal; Muscular Atrophy; NADPH Oxidase 4; Neoplasms; NF-kappa B; Oxidation-Reduction; Pancreatic Neoplasms; Protein Stability; Reactive Oxygen Species; Resveratrol; Signal Transduction; Sirtuin 1; Wasting Syndrome | 2020 |
Resveratrol binds and inhibits transcription factor HIF-1α in pancreatic cancer.
Topics: Antineoplastic Agents, Phytogenic; Cell Hypoxia; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Pancreatic Neoplasms; Resveratrol; Stilbenes | 2020 |
Gemcitabine potentiates anti-tumor effect of resveratrol on pancreatic cancer via down-regulation of VEGF-B.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers, Tumor; Cell Proliferation; Deoxycytidine; Drug Synergism; Female; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; Resveratrol; Tumor Cells, Cultured; Vascular Endothelial Growth Factor B; Xenograft Model Antitumor Assays | 2021 |
Combinations of Phytochemicals More Efficiently than Single Components Activate Nrf2 and Induce the Expression of Antioxidant Enzymes in Pancreatic Cancer Cells.
Topics: Antioxidants; Glycogen Synthase Kinase 3 beta; Humans; Isothiocyanates; NF-E2-Related Factor 2; Pancreatic Neoplasms; Phytochemicals; Resveratrol | 2022 |
Resveratrol-Induced Downregulation of NAF-1 Enhances the Sensitivity of Pancreatic Cancer Cells to Gemcitabine via the ROS/Nrf2 Signaling Pathways.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Down-Regulation; Gemcitabine; Humans; Mitochondria; NF-E2-Related Factor 2; Pancreatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Resveratrol; Ribonucleoproteins; RNA Interference; RNA, Small Interfering; Signal Transduction; Stilbenes | 2018 |
Comparative study of the therapeutic effect of Doxorubicin and Resveratrol combination on 2D and 3D (spheroids) cell culture models.
Topics: Antineoplastic Agents; Cell Culture Techniques; Cell Line, Tumor; Cell Survival; Doxorubicin; Humans; Pancreatic Neoplasms; Resveratrol; Spheroids, Cellular | 2018 |
Resveratrol enhances the chemotherapeutic response and reverses the stemness induced by gemcitabine in pancreatic cancer cells via targeting SREBP1.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Gemcitabine; Humans; Lipids; Mice; Mice, Transgenic; Neoplastic Stem Cells; Pancreas; Pancreatic Neoplasms; Resveratrol; RNA Interference; RNA, Small Interfering; Signal Transduction; Sterol Regulatory Element Binding Protein 1; Xenograft Model Antitumor Assays | 2019 |
Triacetyl resveratrol upregulates miRNA‑200 and suppresses the Shh pathway in pancreatic cancer: A potential therapeutic agent.
Topics: Cell Line, Tumor; Cell Proliferation; Cell Survival; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Hedgehog Proteins; Humans; MicroRNAs; Pancreatic Neoplasms; Resveratrol; Signal Transduction; Up-Regulation | 2019 |
Combination treatment of resveratrol and capsaicin radiosensitizes pancreatic tumor cells by unbalancing DNA repair response to radiotherapy towards cell death.
Topics: Animals; Capsaicin; Cell Death; Chemoradiotherapy; DNA Repair; Drug Therapy, Combination; Humans; Mice; Pancreatic Neoplasms; Radiation-Sensitizing Agents; Resveratrol; Xenograft Model Antitumor Assays | 2019 |
Resveratrol inhibits the epithelial-mesenchymal transition of pancreatic cancer cells via suppression of the PI-3K/Akt/NF-κB pathway.
Topics: Antineoplastic Agents; Cadherins; Cell Line, Tumor; Cell Movement; Chromones; Epithelial-Mesenchymal Transition; Humans; Matrix Metalloproteinases; Morpholines; NF-kappa B; Pancreatic Neoplasms; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Proto-Oncogene Proteins c-akt; Resveratrol; Signal Transduction; Stilbenes; Transforming Growth Factor beta; Vimentin | 2013 |
Resveratrol plays dual roles in pancreatic cancer cells.
Topics: Apoptosis; bcl-2-Associated X Protein; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Pancreatic Neoplasms; Resveratrol; RNA, Small Interfering; Stilbenes; Vascular Endothelial Growth Factor B | 2014 |
Conformational changes and translocation of tissue-transglutaminase to the plasma membranes: role in cancer cell migration.
Topics: Calcium Signaling; Cell Line, Tumor; Cell Membrane; Cell Movement; Gene Expression Regulation, Neoplastic; GTP-Binding Proteins; Humans; Pancreatic Neoplasms; Protein Conformation; Protein Glutamine gamma Glutamyltransferase 2; Protein Transport; Resveratrol; Stilbenes; Transglutaminases | 2014 |
Effect of resveratrol on proliferation and apoptosis of human pancreatic cancer MIA PaCa-2 cells may involve inhibition of the Hedgehog signaling pathway.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Fluorouracil; Hedgehog Proteins; Humans; Pancreatic Neoplasms; Patched Receptors; Patched-1 Receptor; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Resveratrol; Signal Transduction; Smoothened Receptor; Stilbenes | 2014 |
Chemopreventive effect of resveratrol and apocynin on pancreatic carcinogenesis via modulation of nuclear phosphorylated GSK3β and ERK1/2.
Topics: Acetophenones; Adenocarcinoma; Animals; Anticarcinogenic Agents; Antioxidants; Blotting, Western; Carcinogenesis; Cell Line, Tumor; Cell Nucleus; Cell Survival; Chemoprevention; Cricetinae; Disease Models, Animal; Female; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Immunohistochemistry; MAP Kinase Signaling System; Mesocricetus; Pancreatic Neoplasms; Phosphorylation; Resveratrol; Stilbenes | 2015 |
Resveratrol inhibits hypoxia-driven ROS-induced invasive and migratory ability of pancreatic cancer cells via suppression of the Hedgehog signaling pathway.
Topics: Cell Hypoxia; Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Hedgehog Proteins; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Matrix Metalloproteinase 2; Neoplasm Invasiveness; Pancreatic Neoplasms; Reactive Oxygen Species; Resveratrol; Signal Transduction; Stilbenes; Urokinase-Type Plasminogen Activator | 2016 |
Resveratrol inhibits hyperglycemia-driven ROS-induced invasion and migration of pancreatic cancer cells via suppression of the ERK and p38 MAPK signaling pathways.
Topics: Acetylcysteine; Cell Line, Tumor; Cell Movement; Diabetes Complications; Flavonoids; Free Radical Scavengers; Gene Expression Regulation, Neoplastic; Glucose; Humans; Hyperglycemia; Imidazoles; MAP Kinase Signaling System; Neoplasm Invasiveness; p38 Mitogen-Activated Protein Kinases; Pancreatic Neoplasms; Pyridines; Reactive Oxygen Species; Resveratrol; Stilbenes | 2016 |
Classical and atypical resistance of cancer cells as a target for resveratrol.
Topics: Antioxidants; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Flow Cytometry; Fluorescent Antibody Technique; Humans; Pancreatic Neoplasms; Resveratrol; Stilbenes | 2016 |
In vitro comparative studies of resveratrol and triacetylresveratrol on cell proliferation, apoptosis, and STAT3 and NFκB signaling in pancreatic cancer cells.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Humans; Neoplasm Proteins; NF-kappa B; Pancreatic Neoplasms; Resveratrol; Signal Transduction; STAT3 Transcription Factor; Stilbenes | 2016 |
YAP Inhibition by Resveratrol via Activation of AMPK Enhances the Sensitivity of Pancreatic Cancer Cells to Gemcitabine.
Topics: Adaptor Proteins, Signal Transducing; AMP-Activated Protein Kinases; Antineoplastic Agents; Cell Line, Tumor; Deoxycytidine; Enzyme Inhibitors; Gemcitabine; Gene Expression Regulation, Enzymologic; Humans; Pancreatic Neoplasms; Phosphoproteins; Resveratrol; RNA Interference; Signal Transduction; Stilbenes; Transcription Factors; YAP-Signaling Proteins | 2016 |
Metformin potentiates anti-tumor effect of resveratrol on pancreatic cancer by down-regulation of VEGF-B signaling pathway.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Survival; Down-Regulation; Drug Synergism; Humans; Hypoglycemic Agents; Metformin; Mice, Nude; Pancreatic Neoplasms; Resveratrol; RNA Interference; Signal Transduction; Stilbenes; Vascular Endothelial Growth Factor B; Xenograft Model Antitumor Assays | 2016 |
Resveratrol and capsaicin used together as food complements reduce tumor growth and rescue full efficiency of low dose gemcitabine in a pancreatic cancer model.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Capsaicin; Cell Cycle; Cell Line, Tumor; Deoxycytidine; Dose-Response Relationship, Drug; Gemcitabine; Humans; Mice; Mice, Nude; Pancreatic Neoplasms; Resveratrol; Signal Transduction; Stilbenes | 2017 |
Inhibition of cell proliferation by a resveratrol analog in human pancreatic and breast cancer cells.
Topics: Antineoplastic Agents; Aurora Kinase B; Aurora Kinases; Binding Sites; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Colchicine; Cyclin B; Cyclin B1; G2 Phase; Humans; Microtubules; Models, Molecular; Pancreatic Neoplasms; Protein Serine-Threonine Kinases; Resveratrol; Stilbenes; Tubulin | 2009 |
The phytostilbene resveratrol induces apoptosis in INS-1E rat insulinoma cells.
Topics: Animals; Apoptosis; Caspases; Cell Cycle; Cell Line, Tumor; Dactinomycin; Insulin; Insulin-Secreting Cells; Insulinoma; Pancreatic Neoplasms; Phosphatidylserines; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Resveratrol; Signal Transduction; Stilbenes; Time Factors | 2009 |
Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Carcinoma, Pancreatic Ductal; Cell Cycle; Cell Proliferation; Cyclooxygenase 2; Deoxycytidine; Gemcitabine; Humans; Immunoenzyme Techniques; In Vitro Techniques; Male; Mice; Mice, Nude; NF-kappa B; Pancreatic Neoplasms; Resveratrol; Stilbenes; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2010 |
Resveratrol, a red wine polyphenol, suppresses pancreatic cancer by inhibiting leukotriene A₄hydrolase.
Topics: Animals; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epoxide Hydrolases; Flavonoids; Hep G2 Cells; Humans; Leukotriene B4; Mice; Mice, Nude; Models, Molecular; Pancreatic Neoplasms; Phenols; Polyphenols; Protein Binding; Protein Structure, Secondary; Protein Structure, Tertiary; Resveratrol; RNA Interference; Stilbenes; Time Factors; Wine; Xenograft Model Antitumor Assays | 2010 |
Antiproliferative effect of resveratrol in pancreatic cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Caspases; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Humans; Pancreatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Resveratrol; Stilbenes; X-Linked Inhibitor of Apoptosis Protein | 2010 |
Resveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition.
Topics: Animals; Antioxidants; Apoptosis; Cell Movement; Epithelial-Mesenchymal Transition; Humans; Mice; Mice, Transgenic; Neoplastic Stem Cells; Pancreatic Neoplasms; Pluripotent Stem Cells; Proto-Oncogene Proteins p21(ras); Resveratrol; Stilbenes; Transcription Factors | 2011 |
Resveratrol-induced apoptosis is enhanced in low pH environments associated with cancer.
Topics: Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Chelating Agents; Copper; DNA Damage; DNA Fragmentation; Histones; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Lymphocytes; Models, Biological; Pancreatic Neoplasms; Resveratrol; Stilbenes; Tumor Microenvironment | 2012 |
Resveratrol induces apoptosis in pancreatic cancer cells.
Topics: Apoptosis; Blotting, Western; Caspase 3; Cell Survival; Humans; Mitogen-Activated Protein Kinases; Pancreatic Neoplasms; Resveratrol; Stilbenes; Tumor Cells, Cultured | 2011 |
Resveratrol inhibits growth of orthotopic pancreatic tumors through activation of FOXO transcription factors.
Topics: Apoptosis; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Survival; Forkhead Transcription Factors; Humans; Mitogen-Activated Protein Kinases; Pancreatic Neoplasms; Resveratrol; Signal Transduction; Stilbenes | 2011 |
Resveratrol mobilizes Ca2+ from intracellular stores and induces c-Jun N-terminal kinase activation in tumoral AR42J cells.
Topics: Animals; Antioxidants; Calcium; Cell Line, Tumor; Cell Survival; Endoplasmic Reticulum; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Pancreatic Neoplasms; Rats; Resveratrol; Sincalide; Stilbenes; Thapsigargin | 2012 |
Resveratrol inhibits proliferation and induces apoptosis through the hedgehog signaling pathway in pancreatic cancer cell.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Hedgehog Proteins; Humans; Pancreatic Neoplasms; Resveratrol; Stilbenes | 2011 |
Resveratrol induces apoptosis of pancreatic cancers cells by inhibiting miR-21 regulation of BCL-2 expression.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Pancreatic Ducts; Pancreatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Resveratrol; Stilbenes; Tetrazolium Salts; Thiazoles | 2013 |
Resveratrol inhibits proliferation and induces apoptosis in human pancreatic cancer cells.
Topics: Anticarcinogenic Agents; Apoptosis; Cell Division; Coloring Agents; DNA; Dose-Response Relationship, Drug; Humans; In Situ Nick-End Labeling; Kinetics; Pancreatic Neoplasms; Propidium; Resveratrol; Stilbenes; Thymidine; Tumor Cells, Cultured | 2002 |
Sensitization for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by the chemopreventive agent resveratrol.
Topics: Anticarcinogenic Agents; Apoptosis; Apoptosis Regulatory Proteins; Base Sequence; Brain Neoplasms; Breast Neoplasms; Caspase Inhibitors; Caspases; Cell Cycle; Cell Division; Cell Line, Tumor; Cysteine Proteinase Inhibitors; DNA Primers; Female; Humans; Male; Melanoma; Membrane Glycoproteins; Pancreatic Neoplasms; Prostatic Neoplasms; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Stilbenes; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha | 2004 |
Protective effects of benzyl isothiocyanate and sulforaphane but not resveratrol against initiation of pancreatic carcinogenesis in hamsters.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Carcinogenicity Tests; Carcinogens; Cell Transformation, Neoplastic; Cricetinae; Cyclooxygenase 2; Diet; Injections, Subcutaneous; Isothiocyanates; Male; Membrane Proteins; Mesocricetus; Neoplasms, Experimental; Nitrosamines; Pancreatic Neoplasms; Resveratrol; Stilbenes; Sulfoxides; Thiocyanates | 2006 |
Resveratrol inhibits pancreatic cancer cell proliferation through transcriptional induction of macrophage inhibitory cytokine-1.
Topics: Antineoplastic Agents, Phytogenic; Bone Morphogenetic Proteins; Cell Division; Cell Line, Tumor; Dactinomycin; Gene Expression Regulation, Neoplastic; Growth Differentiation Factor 15; Humans; Nucleic Acid Synthesis Inhibitors; Oligonucleotide Array Sequence Analysis; Pancreatic Neoplasms; Resveratrol; RNA, Small Interfering; Stilbenes; Transcription, Genetic; Transfection; Up-Regulation | 2007 |
Anti-cancer effect of resveratrol is associated with induction of apoptosis via a mitochondrial pathway alignment.
Topics: Anticarcinogenic Agents; Apoptosis; Benzimidazoles; Carbocyanines; Cell Death; Cell Line, Tumor; Dose-Response Relationship, Drug; Fluoresceins; Fluorescent Dyes; Humans; Membrane Potentials; Mitochondria; Mitochondrial Membranes; Pancreatic Neoplasms; Reactive Oxygen Species; Resveratrol; Stilbenes | 2008 |
Resveratrol pretreatment desensitizes AHTO-7 human osteoblasts to growth stimulation in response to carcinoma cell supernatants.
Topics: Alkaline Phosphatase; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carcinoma, Renal Cell; Cell Differentiation; Cell Line; Culture Media, Conditioned; Estrogens, Non-Steroidal; Female; Humans; Isoflavones; Kidney Neoplasms; Lung; Male; Osteoblasts; Pancreatic Neoplasms; Phytoestrogens; Plant Preparations; Prostatic Neoplasms; Resveratrol; Stilbenes; Tamoxifen; Tumor Cells, Cultured | 1999 |